Jill Quigley
Director/Board Member bei TERNS PHARMACEUTICALS, INC.
Vermögen: 196 800 $ am 31.03.2024
Profil
Jill Thompson Quigley is an Independent Director at Terns Pharmaceuticals, Inc. since 2020 and a Director at Chemomab Therapeutics Ltd.
since 2022.
Previously, she served as the Chief Executive Officer & General Counsel at Nutrinia Ltd.
from 2016 to 2018, Assistant Corporate Counsel at Integra LifeSciences Holdings Corp.
from 2009 to 2011, Corporate Counsel at Pharmasset, Inc. from 2011 to 2012, Senior Legal Counsel at Shire Plc from 2012 to 2016, Associate at Dechert LLP from 2006 to 2009, Chief Operating Officer at Passage Bio, Inc. from 2018 to 2021, and Senior Counsel at NPS Pharmaceuticals, Inc. from 2012 to 2015.
She obtained her undergraduate degree from American University in 1997 and her graduate degree from Rutgers Law School in 2005.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 23.01.2024 | 30 000 ( 0,05% ) | 196 800 $ | 31.03.2024 | |
| 28.03.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Jill Quigley
| Unternehmen | Position | Beginn |
|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Director/Board Member | 01.12.2020 |
| CHEMOMAB THERAPEUTICS LTD. | Director/Board Member | 21.06.2022 |
Ehemalige bekannte Positionen von Jill Quigley
| Unternehmen | Position | Ende |
|---|---|---|
| PASSAGE BIO, INC. | Chief Operating Officer | 31.12.2021 |
Nutrinia Ltd.
 Nutrinia Ltd. Pharmaceuticals: MajorHealth Technology Nutrinia Ltd. develops bioactive feed supplements for infant formulas and animal feed. The firm is involved in broad intellectual property protection, industrial processes envelopment, conducting additional clinical trials and obtaining regulatory approval for the supplementation of pre-term and infant formulas with Insulin. The company was founded by Naim Shehadeh in 2003 and is headquartered in Ramat-Gan, Israel. | Chief Executive Officer | 01.11.2018 |
| SHIRE | General Counsel | 01.01.2016 |
| NPS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.11.2015 |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Corporate Officer/Principal | 01.07.2012 |
Ausbildung von Jill Quigley
| American University | Undergraduate Degree |
| Rutgers Law School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | Health Technology |
| TERNS PHARMACEUTICALS, INC. | Health Technology |
| PASSAGE BIO, INC. | Health Technology |
| CHEMOMAB THERAPEUTICS LTD. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Dechert LLP
 Dechert LLP Miscellaneous Commercial ServicesCommercial Services Dechert LLP provides legal services. It serves the chemical, construction, finance and real estate, energy, insurance, and health sectors. The firm's practice areas include business restructuring and reorganization, commercial litigation, corporate and securities, energy, finance and real estate, financial services, mergers and acquisitions, and private equity. The company was founded in 1875 and is headquartered in Philadelphia, PA. | Commercial Services |
Nutrinia Ltd.
Nutrinia Ltd. Pharmaceuticals: MajorHealth Technology Nutrinia Ltd. develops bioactive feed supplements for infant formulas and animal feed. The firm is involved in broad intellectual property protection, industrial processes envelopment, conducting additional clinical trials and obtaining regulatory approval for the supplementation of pre-term and infant formulas with Insulin. The company was founded by Naim Shehadeh in 2003 and is headquartered in Ramat-Gan, Israel. | Health Technology |
